Cannabis Lab Set Up in Hebrew University With $2.3 Million Investment
The investment was made by Asana Bio Group, an Israeli company specializing in cannabinoid-based treatments in the women's health field
A $2.3 million investment has seen a cannabinoid research lab called Lumir Lab established on the campus of the Hebrew University of Jerusalem. The investment came from Asana Bio Group Ltd., an Israeli holding company specializing in medical cannabis ventures, an Asana spokesperson told Calcalist. Asana CEO and co-founder Yotam Hod will also manage the lab.
For daily updates, subscribe to our newsletter by clicking here.Set up in 2017 but only very recently licensed by the Israeli health ministry, the lab will provide clinical validation, analyses, and solutions to companies operating in the medical cannabis industry, as well as custom product formulations, cannabinoids and terpenes profiling, and product compliance services.